LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 93 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $156,056,000 | 45.49% |
| Foresite Capital Management IV, LLC | 13,282,181 | $102,804,000 | 21.15% |
| Apoletto Ltd | 15,093,969 | $116,827,000 | 14.55% |
| SB Management Ltd | 3,500,000 | $27,090,000 | 2.68% |
| HSG Holding Ltd | 3,045,997 | $23,576,000 | 2.11% |
| MIC Capital Management UK LLP | 1,320,000 | $10,217,000 | 1.95% |
| Alphabet Inc. | 5,865,125 | $45,396,000 | 1.10% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $12,754,000 | 0.80% |
| Adero Partners, LLC | 491,372 | $3,803,000 | 0.62% |
| Ergoteles LLC | 1,008,428 | $7,805,000 | 0.30% |